- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-17-0024422

About Kamla Lifesciences Limited
Data last updated:
Kamla Lifesciences Limited is a public limited company based in Boisar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2012PLC228772. Its GSTIN is 27AAECK7593H1Z2 (Maharashtra).
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹30 Cr. It was formerly known as Kamla Lifesciences Private Limited. It is led by directors including Digambar Jaikishan Zawar (Managing Director) and Milind Balwant Save.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No G – 84/1 MIDC Tarapur Boisar, Maharashtra, India – 401506.
As per the financials filed for FY 2025, the company reported a revenue of ₹85.4 Cr, a growth of 82% compared to the previous year. For the same year it recorded a net loss of ₹1.65 Cr (net margin -1.9%) and EBITDA of ₹14.58 Cr (EBITDA margin 17.1%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
The company has about 221 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹65 Cr on record.
Kamla Lifesciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0024422). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kamallifescience.com.
Company details
Name history
Kamla Lifesciences has undergone 2 name changes throughout its history. The company was previously known as Kamla Lifesciences Limited, and Kamla Lifesciences Private Limited. The current legal name is Kamla Lifesciences Limited.
| Company Name | Status |
|---|---|
| Kamla Lifesciences Limited | Current |
| Kamla Lifesciences Private Limited | Previous |
CIN history
Kamla Lifesciences has one previous CIN (Corporate Identification Number): U24233MH2012PTC228772. The current CIN is U24233MH2012PLC228772, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233MH2012PLC228772 | Current |
| U24233MH2012PTC228772 | Previous |
Recognitions & Rankings of Kamla Lifesciences
Contact details
Kamla Lifesciences Limited's registered office is in Boisar, Maharashtra. Its website is kamallifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No G – 84/1 MIDC Tarapur Boisar, Maharashtra, India – 401506
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kamla Lifesciences Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kamla Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kamla Lifesciences Limited, buy the company report.
Financials of Kamla Lifesciences Limited
FY 2025 filings availableKamla Lifesciences Limited reported revenue of ₹85.4 Cr (up 82% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over three years, including 82% growth in the latest year. EBITDA rose 873% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹85.4 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.58 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.1% | ||||
| Net Profit Margin | -1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kamla Lifesciences Limited, buy the company report.
Board of directors of Kamla Lifesciences Limited
Kamla Lifesciences has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Milind Balwant Save Also directs: Pharchem Private Limited, Enicar Pharmaceuticals Private Limited | Director | 04 Jan 2016 | 10 Years 10 Months | Current |
| Digambar Jaikishan Zawar | Managing Director | 27 Mar 2012 | 14 Years 7 Months | Current |
| Pushkar Digambar Zawar | Additional Director | 03 Feb 2026 | 0 Years 9 Months | Current |
| Ketan Baldevdas Mistry | Director | 19 Jun 2023 | 3 Years 5 Months | Current |
| Dilip Vasudeo Gupta | Director | 19 Jun 2023 | 3 Years 5 Months | Current |
Peer comparison
Kamla Lifesciences Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kamla Lifesciences Limitedthis company | ₹85.4 Cr (FY 2025) | -₹1.65 Cr | -1.9% | 82.0% | 221 | Boisar, Maharashtra, India |
| Aerol Formulations Private Limited | ₹55.39 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Sndev Healthcare Limited | ₹55.17 Cr (FY 2025) | 14.0% | Kandivlai West, Maharashtra, India | |||
| Cu-V-Kar Genetic Medicine Private Limited | ₹55.11 Cr (FY 2024) | 38.0% | Chennai, Tamil Nadu, India | |||
| Vim Meditech Private Limited | ₹53.98 Cr (FY 2024) | 13.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Kamla Lifesciences Limited, buy the company report.
Auditor
Kamla Lifesciences Limited is audited by Raamas & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Raamas & Associates | FY 2023 | 124011W |
Shareholding
The shareholding of Kamla Lifesciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kamla Lifesciences Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jul 2021 | 100471519 | Hdfc Bank Limited | ₹25 Cr | Open | |
| 23 Aug 2019 | 100284917 | Hdfc Bank Limited | ₹5 Cr | Open | |
| 23 Aug 2019 | 100286161 | Hdfc Bank Limited | ₹15 Cr | Open | |
| 09 Aug 2019 | 100283107 | Hdfc Bank Limited | ₹20 Cr | Open |
To see the full charge records of Kamla Lifesciences Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Kamla Lifesciences Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kamla Lifesciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Kamla Lifesciences has 2 subsidiary companies and 5 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Kamford Healthcare Private Limited | U24239MH2019PTC331192 | |
| KLL Healthcare Private Limited | U24299MH2021PTC362414 |
To see the full group structure of Kamla Lifesciences Limited, buy the company report.
Employees & EPFO
Kamla Lifesciences Limited has a workforce of 221 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 221 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 |
To see the full employee and EPFO history of Kamla Lifesciences Limited, buy the company report.
GST
Kamla Lifesciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECK7593H1Z2 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kamla Lifesciences Limited, buy the company report.
Recent activity
Kamla Lifesciences Limited has 8 board changes on record since 2012: 5 appointments and 3 cessations. The latest: Pushkar Digambar Zawar was appointed as Additional Director on 03 Feb 2026.
4 earlier events are in the company report.
Frequently asked questions
Kamla Lifesciences is an active public limited company based in Boisar, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 2012 (14+ years old) and is registered under CIN U24233MH2012PLC228772.
Kamla Lifesciences has 5 current directors:
- Digambar Jaikishan Zawar - Managing Director
- Milind Balwant Save - Director
- Pushkar Digambar Zawar - Additional Director
- Ketan Baldevdas Mistry - Director
- Dilip Vasudeo Gupta - Director
The latest financial statements of Kamla Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kamla Lifesciences is 27AAECK7593H1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kamla Lifesciences is U24233MH2012PLC228772. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kamla Lifesciences was incorporated on 27 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Kamla Lifesciences by revenue are Aerol Formulations Private Limited, Sndev Healthcare Limited, Cu-V-Kar Genetic Medicine Private Limited, Vim Meditech Private Limited, all in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pushkar Digambar Zawar was appointed as Additional Director on 03 Feb 2026. Dilip Vasudeo Gupta ceased to be Additional Director on 29 Sep 2023. Ketan Baldevdas Mistry ceased to be Additional Director on 29 Sep 2023. Kamla Lifesciences has 8 board changes on record in total.
Yes, Kamla Lifesciences is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-17-0024422).
Kamla Lifesciences can be reached through the website kamallifescience.com. Its registered office is in Boisar, Maharashtra, India.
The registered office of Kamla Lifesciences is at Plot No G – 841 MIDC Tarapur Boisar, Maharashtra, India – 401506.

